JPMorgan Downgrades Pacific Biosciences of California (PACB) to Underweight
Tweet Send to a FriendGet Alerts PACB Hot Sheet
Price: $2.54 +1.60%
Rating Summary:
1 Buy, 4 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
1 Buy, 4 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade PACB Now!
JPMorgan downgraded Pacific Biosciences of California (NASDAQ: PACB) from Neutral to Underweight, maintains price target of $8.00.
For more ratings news on Pacific Biosciences of California click here and for the rating history of Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.56 yesterday, with a 52 week range of $5.20-$17.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Pacific Biosciences of California click here and for the rating history of Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.56 yesterday, with a 52 week range of $5.20-$17.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- First Time Cruisers Pass on Carnival (CCL); Wells Fargo Cuts to Market Perform
- Sterne Agee Downgrades Oil States International (OIS) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
